ArcticZymes Technologies ASA B4V.F Stock
ArcticZymes Technologies ASA Price Chart
ArcticZymes Technologies ASA B4V.F Financial and Trading Overview
| ArcticZymes Technologies ASA stock price | 2.06 EUR |
| Previous Close | 3.47 EUR |
| Open | 3.44 EUR |
| Bid | 3.36 EUR x 670000 |
| Ask | 3.47 EUR x 660000 |
| Day's Range | 3.44 - 3.44 EUR |
| 52 Week Range | 3.05 - 8.99 EUR |
| Volume | 720 EUR |
| Avg. Volume | 58 EUR |
| Market Cap | 173.97M EUR |
| Beta (5Y Monthly) | 1.062835 |
| PE Ratio (TTM) | 114.66667 |
| EPS (TTM) | 0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
B4V.F Valuation Measures
| Enterprise Value | -33996568 EUR |
| Trailing P/E | 114.66667 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.453772 |
| Price/Book (mrq) | 0.6011884 |
| Enterprise Value/Revenue | -0.284 |
| Enterprise Value/EBITDA | -2.096 |
Trading Information
ArcticZymes Technologies ASA Stock Price History
| Beta (5Y Monthly) | 1.062835 |
| 52-Week Change | -53.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.99 EUR |
| 52 Week Low | 3.05 EUR |
| 50-Day Moving Average | 3.35 EUR |
| 200-Day Moving Average | 5.08 EUR |
B4V.F Share Statistics
| Avg. Volume (3 month) | 58 EUR |
| Avg. Daily Volume (10-Days) | 72 EUR |
| Shares Outstanding | 50.57M |
| Float | 42.87M |
| Short Ratio | N/A |
| % Held by Insiders | 34.44% |
| % Held by Institutions | 19.65% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 14.27% |
| Operating Margin (ttm) | 11.91% |
| Gross Margin | 95.50% |
| EBITDA Margin | 13.55% |
Management Effectiveness
| Return on Assets (ttm) | 2.91% |
| Return on Equity (ttm) | 6.15% |
Income Statement
| Revenue (ttm) | 119.67M EUR |
| Revenue Per Share (ttm) | 2.38 EUR |
| Quarterly Revenue Growth (yoy) | -36.60% |
| Gross Profit (ttm) | 132.48M EUR |
| EBITDA | 16.22M EUR |
| Net Income Avi to Common (ttm) | 17.08M EUR |
| Diluted EPS (ttm) | 0.03 |
| Quarterly Earnings Growth (yoy) | -75.79% |
Balance Sheet
| Total Cash (mrq) | 232.48M EUR |
| Total Cash Per Share (mrq) | 4.6 EUR |
| Total Debt (mrq) | 13.65M EUR |
| Total Debt/Equity (mrq) | 4.72 EUR |
| Current Ratio (mrq) | 14.102 |
| Book Value Per Share (mrq) | 5.722 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 35.04M EUR |
| Levered Free Cash Flow (ttm) | 7.21M EUR |
Profile of ArcticZymes Technologies ASA
| Country | Germany |
| State | N/A |
| City | Tromsø |
| Address | Sykehusveien 23 |
| ZIP | 9294 |
| Phone | 47 77 64 89 00 |
| Website | https://arcticzymes.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 60 |
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.
Q&A For ArcticZymes Technologies ASA Stock
What is a current B4V.F stock price?
ArcticZymes Technologies ASA B4V.F stock price today per share is 2.06 EUR.
How to purchase ArcticZymes Technologies ASA stock?
You can buy B4V.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ArcticZymes Technologies ASA?
The stock symbol or ticker of ArcticZymes Technologies ASA is B4V.F.
Which industry does the ArcticZymes Technologies ASA company belong to?
The ArcticZymes Technologies ASA industry is Biotechnology.
How many shares does ArcticZymes Technologies ASA have in circulation?
The max supply of ArcticZymes Technologies ASA shares is 52.13M.
What is ArcticZymes Technologies ASA Price to Earnings Ratio (PE Ratio)?
ArcticZymes Technologies ASA PE Ratio is 68.50000000 now.
What was ArcticZymes Technologies ASA earnings per share over the trailing 12 months (TTM)?
ArcticZymes Technologies ASA EPS is 0.03 EUR over the trailing 12 months.
Which sector does the ArcticZymes Technologies ASA company belong to?
The ArcticZymes Technologies ASA sector is Healthcare.